+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury



Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury



Peptides 29(5): 770-777



Circulating urotensin II (UII) concentrations and the tissue expression of its cognate receptor (UT) are elevated in patients with cardiovascular disease (CVD). The functional significance of elevated plasma UII levels in CVD is unclear. Urotensin-related peptide (URP) is a paralog of UII in that it contains the six amino acid ring structures found in UII. Although both peptides are implicated as bioactive factors capable of modulating cardiovascular status, the role of both UII and URP in ischemic injury is unknown. Accordingly, we provide here the first report describing the direct cardiac effects of UII and URP in ischemia-reperfusion injury. Isolated perfused rat hearts were subjected to no-flow global ischemia for 45 min after 30min preconditioning with either 1nM rUII or 10nM URP. Both rUII- and URP-induced significant vasodilation of coronary arteries before (both P<0.05) and after ischemia (both P<0.05). Rat UII alone lowered contractility prior to ischemia (P=0.053). Specific assay of perfusate revealed rUII and URP both significantly inhibited reperfusion myocardial creatine kinase (CK) release (P=0.012 and 0.036, respectively) and atrial natriuretic peptide (ANP) secretion (P=0.025). Antagonism of the UT receptor with 1muM palosuran caused a significant increase in perfusion pressure (PP) prior to and post-ischemia. Furthermore, palosuran significantly inhibited reductions in both PP and myocardial damage marker release induced by both rUII and URP. In conclusion, our data suggests rUII and URP reduce cardiac ischemia-reperfusion injury by increasing flow through the coronary circulation, reducing contractility and therefore myocardial energy demand, and inhibiting reperfusion myocardial damage. Thus, UII and URP present as novel peptides with potential cardioprotective actions.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144650

Download citation: RISBibTeXText

PMID: 17900760

DOI: 10.1016/j.peptides.2007.08.013


Related references

Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction. Journal of Neurochemistry 107(2): 361-374, 2008

Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1. Peptides 30(6): 1124-1129, 2009

Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochemical and Biophysical Research Communications 310(3): 860-868, 2003

Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain. Peptides 25(10): 1815-1818, 2004

Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5. Peptides 29(5): 711-720, 2008

A wearable exoskeleton suit for motion assistance to paralysed patients. Journal of Orthopaedic Translation 11: 7-18, 2018

Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis. Peptides 31(8): 1511-1516, 2010

The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure. Peptides 40: 72-76, 2014

Urotensin II and urotensin II-related peptide regulate normal astrocyte activity. Potential involvement in glioma proliferation. 2007

International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function. Pharmacological Reviews 67(1): 214-258, 2015

Concordant localization of functional urotensin II and urotensin II-related peptide binding sites in the rat brain: Atypical occurrence close to the fourth ventricle. Journal of Comparative Neurology 522(11): 2634-2649, 2015

The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation. Biochemical Journal 428(1): 113-124, 2010

Urotensin II, urotensin II-related peptide and their receptors. 2007

Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 132(3): 689-696, 2005

Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts. Peptides 27(12): 3261-3268, 2006